The Valley Desk

NCT01435369 · Interventional trial

Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma

Overall registry status Completed

Phase 2

Conditions Malignant Melanoma, Melanoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov